We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$8.27B
AUM Growth
+$555M
Cap. Flow
+$466M
Cap. Flow %
5.63%
Top 10 Hldgs %
27.66%
Holding
409
New
6
Increased
189
Reduced
152
Closed
18

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$98.2M
2
AMGN icon
Amgen
AMGN
+$71.4M
3
TXN icon
Texas Instruments
TXN
+$39.2M
4
MMM icon
3M
MMM
+$22M
5
TFC icon
Truist Financial
TFC
+$19.2M

Top Sells

Rank Stock Value
1
SJM icon
J.M. Smucker
SJM
+$33M
2
KMB icon
Kimberly-Clark
KMB
+$32.7M
3
O icon
Realty Income
O
+$26.9M
4
JCI icon
Johnson Controls International
JCI
+$20.1M
5
ABBV icon
AbbVie
ABBV
+$19.7M

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Technology 16.64%
3 Consumer Staples 15.19%
4 Financials 12.88%
5 Industrials 11.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDK
201
DELISTED
CDK Global, Inc.
CDK
$1.39M 0.02%
24,169
-872
-3% -$50.2K
MSFG
202
DELISTED
MainSource Financial Group Inc
MSFG
$1.38M 0.02%
55,390
+13,280
+32% +$307K
HI
203
DELISTED
Hillenbrand
HI
$1.36M 0.02%
43,073
JJSF icon
204
J&J Snack Foods
JJSF
$1.48B
$1.34M 0.02%
11,260
+1,025
+10% +$124K
CVS icon
205
CVS Health
CVS
$133B
$1.32M 0.02%
14,891
+288
+2% +$27.2K
VWO icon
206
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$1.28M 0.02%
34,002
-500
-1% -$18.6K
DGX icon
207
Quest Diagnostics
DGX
$25.6B
$1.27M 0.02%
15,062
+687
+5% +$57.7K
OZK icon
208
Bank OZK
OZK
$5.65B
$1.27M 0.02%
33,157
+1,145
+4% +$43.4K
RMAX icon
209
RE/MAX Holdings
RMAX
$195M
$1.26M 0.02%
28,675
+9,955
+53% +$421K
NVEC icon
210
NVE Corp
NVEC
$595M
$1.25M 0.02%
21,231
+525
+3% +$30.5K
MJN
211
DELISTED
Mead Johnson Nutrition Company
MJN
$1.25M 0.02%
15,841
+424
+3% +$36.2K
ABAX
212
DELISTED
Abaxis Inc
ABAX
$1.25M 0.02%
24,168
+2,215
+10% +$111K
STBA icon
213
S&T Bancorp
STBA
$1.85B
$1.24M 0.02%
42,870
+3,055
+8% +$82.3K
BF.B icon
214
Brown-Forman Class B
BF.B
$12.8B
$1.23M 0.01%
40,513
HCKT icon
215
Hackett Group
HCKT
$285M
$1.23M 0.01%
74,405
+6,745
+10% +$103K
CONE
216
DELISTED
CyrusOne Inc Common Stock
CONE
$1.2M 0.01%
+25,165
New +$1.3M
MENT
217
DELISTED
Mentor Graphics Corp
MENT
$1.17M 0.01%
44,169
+4,090
+10% +$92.9K
VAC icon
218
Marriott Vacations Worldwide
VAC
$3.35B
$1.16M 0.01%
15,855
+1,500
+10% +$111K
SNX icon
219
TD Synnex
SNX
$20.3B
$1.16M 0.01%
20,330
+1,810
+10% +$93.3K
IWM icon
220
iShares Russell 2000 ETF
IWM
$83B
$1.15M 0.01%
9,230
-994
-10% -$121K
VOD icon
221
Vodafone
VOD
$36.1B
$1.13M 0.01%
38,882
ZTS icon
222
Zoetis
ZTS
$31.9B
$1.1M 0.01%
21,177
-282
-1% -$14.3K
VMI icon
223
Valmont Industries
VMI
$9.43B
$1.09M 0.01%
8,128
+735
+10% +$96.9K
IPAR icon
224
Interparfums
IPAR
$4B
$1.09M 0.01%
33,824
+3,125
+10% +$100K
REIS
225
DELISTED
Reis, Inc.
REIS
$1.09M 0.01%
53,245
+3,335
+7% +$72.9K

Similar funds

Bahl & Gaynor's Q3 2016 Portfolio in Review

As of Q3 2016, Bahl & Gaynor held 409 positions worth $8.27B, up 7.2% from $7.71B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Bahl & Gaynor deployed $466M of net new capital in Q3 2016, opening 6 new positions and adding to 189 existing holdings. Its largest new stake was Dollar General: 145,451 shares worth $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was J.M. Smucker, an estimated $33M trimmed.

  • Bahl & Gaynor's largest Q3 2016 buy was Dollar General: 145,451 shares worth $10.2M.
  • Bahl & Gaynor added most to Abbott in Q3 2016, an estimated $98.2M increase.
  • Bahl & Gaynor's biggest Q3 2016 reduction was J.M. Smucker, cutting an estimated $33M.
  • Bahl & Gaynor fully exited Ross Stores in Q3 2016, selling an estimated $864K.
  • Bahl & Gaynor's ten largest holdings make up 28% of its $8.27B portfolio in Q3 2016.
  • Bahl & Gaynor opened 6 new positions and closed 18 in Q3 2016.
  • Bahl & Gaynor's portfolio value rose 7.2% quarter-over-quarter to $8.27B.

Based on Bahl & Gaynor's 13F filing for Q3 2016, filed 7 Nov 2016.